Ainos, Inc. (AIMD) stock forecast & analysis
0.8401
NasdaqCM · USDDelayed by 15 minutes
Down: -0.2199, -20.7%
1 analysis
Latest analysis: · verdict locked
- Open
- 0.9095
- Previous close
- 1.06
- Day range
- 0.8401 – 0.9568
- 52-week range
- 0.4340 – 3.88
- Volume (shares)
- 1.11M
- Net assets
- Not available
- Expense ratio
- Not available
- Shares outstanding
- 8.72M
- P/E ratio
- Not available
- Dividend yield
- 0.00%
- Beta
- 2.69
- Market cap
- 7.32M
Market Scanner’s AI analysis of Ainos, Inc. (AIMD), updated November 2026: Ainos's $9 million AI Nose System order and VELDONA technology transfer contrasted with declining revenue and bearish technical indicators.
This page is the public summary. A signed-in user can run a fresh five-stage AI analysis of Ainos, Inc. (AIMD) and read the full verdict with the bull and bear debate behind it — using Market Scanner tokens, or their own OpenAI or Anthropic key.
Summary
Ainos's $9 million AI Nose System order and VELDONA technology transfer contrasted with declining revenue and bearish technical indicators.
Recent analyses for Ainos, Inc. (AIMD) covered a significant $9 million agreement for AI Nose Systems with ASE, alongside the completion of the VELDONA technology transfer and advancements in chemical data points. However, the reports also noted a substantial year-over-year quarterly revenue decline of -96.7% and a mixed to bearish short-term technical outlook, with long-term indicators suggesting a downtrend.
AIMD news & sentiment
News reports highlighted a significant new agreement for AI Nose Systems and a technology transfer, alongside advancements in data collection. Social media discussion focused on the company's operational progress and substantial order wins.
AIMD technical picture
Technical indicators for AIMD presented a mixed short-term outlook with bearish momentum, while long-term indicators suggested a significant downtrend. Momentum readings were not extreme, but moving averages indicated a bearish trend, contrasted by strong buying pressure shown in the Money Flow Index.
Fundamentals
Ainos, Inc. (AIMD) reported a significant year-over-year quarterly revenue decline. The company's trailing twelve months revenue was minimal, with negative gross profit and substantial net losses evident in recent annual and trailing twelve months figures, alongside a highly negative return on equity.
Factors discussed — upside
- Secured $9 million agreement with ASE for 5,000 AI Nose Systems, the largest order in company history.
- Completed VELDONA technology transfer, triggering a $600,000 license payment.
- Surpassed 3 billion real-world chemical data points, advancing chemical intelligence capabilities.
- Money Flow Index (MFI) at 99.76 indicates strong buying pressure.
Factors discussed — risks
- Year-over-year quarterly revenue growth was -96.7%.
- Trailing twelve months (TTM) revenue stands at 13,600 USD.
- Earnings Per Share (EPS) is -2.54 USD, and Return on Equity (TTM) is -196.3%.
- 10-day Exponential Moving Average (EMA) is significantly below the last close.
- MACD is below its signal line, suggesting bearish momentum.
- Revenue trends
- Technical indicators
- New contracts
- Technology transfer
Summary updated .
AIMD technical indicators
Common technical indicators for AIMD, computed from its daily closing prices.
| Indicator | Value | Reading |
|---|---|---|
| 50-day simple moving average | 1.09 | Price below |
| 10-day exponential moving average | 0.73 | Price above |
| Relative strength index (14-day) | 49.92 | Neutral |
| MACD line (12/26/9) | -0.1007 | Above its signal line |
| Bollinger bands (20-day, 2σ) | 0.45 – 1.04 | Price inside the bands |
Analyses
Recent AIMD.US analyses are locked — sign in to read them or generate a fresh one.
Locked
Unlock in the library — 1 newer report
Sign in to unlock the 2026-11-13 AIMD.US analysis
Get the verdict — free
Frequently asked questions
- What is the bull case for Ainos, Inc.?
- The bull case for Ainos, Inc. centers on significant commercial and technological advancements, including a landmark $9 million AI Nose System agreement with ASE and the successful completion of the VELDONA technology transfer, which generated a substantial license payment. The company has also achieved a major milestone by surpassing 3 billion real-world chemical data points, enhancing its chemical intelligence capabilities, and recent strong buying pressure has been noted.
- What are the risks for Ainos, Inc.?
- The bear case for Ainos, Inc. highlights severe financial headwinds, characterized by a sharp year-over-year quarterly revenue decline of -96.7% and minimal trailing twelve months revenue. Profitability metrics are deeply negative, with a substantial EPS loss and a highly negative Return on Equity. Technical indicators also suggest a bearish short-term outlook with a downtrend indicated by long-term moving averages.
- Is Ainos, Inc. bullish or bearish?
- Recent AI analyses of Ainos, Inc. examined factors on both sides. Discussed upside: The bull case for Ainos, Inc. centers on significant commercial and technological advancements, including a landmark $9 million AI Nose System agreement with ASE and the successful completion of the VELDONA technology transfer, which generated a substantial license payment. The company has also achieved a major milestone by surpassing 3 billion real-world chemical data points, enhancing its chemical intelligence capabilities, and recent strong buying pressure has been noted. Discussed risks: The bear case for Ainos, Inc. highlights severe financial headwinds, characterized by a sharp year-over-year quarterly revenue decline of -96.7% and minimal trailing twelve months revenue. Profitability metrics are deeply negative, with a substantial EPS loss and a highly negative Return on Equity. Technical indicators also suggest a bearish short-term outlook with a downtrend indicated by long-term moving averages. These are descriptive observations, not a recommendation.
- What is the latest sentiment on Ainos, Inc.?
- News reports highlighted a significant new agreement for AI Nose Systems and a technology transfer, alongside advancements in data collection. Social media discussion focused on the company's operational progress and substantial order wins.
- How does Market Scanner analyse Ainos, Inc.?
- Every analysis of Ainos, Inc. runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.Read the methodology
What is the bull case for Ainos, Inc.?
The bull case for Ainos, Inc. centers on significant commercial and technological advancements, including a landmark $9 million AI Nose System agreement with ASE and the successful completion of the VELDONA technology transfer, which generated a substantial license payment. The company has also achieved a major milestone by surpassing 3 billion real-world chemical data points, enhancing its chemical intelligence capabilities, and recent strong buying pressure has been noted.
What are the risks for Ainos, Inc.?
The bear case for Ainos, Inc. highlights severe financial headwinds, characterized by a sharp year-over-year quarterly revenue decline of -96.7% and minimal trailing twelve months revenue. Profitability metrics are deeply negative, with a substantial EPS loss and a highly negative Return on Equity. Technical indicators also suggest a bearish short-term outlook with a downtrend indicated by long-term moving averages.
Is Ainos, Inc. bullish or bearish?
Recent AI analyses of Ainos, Inc. examined factors on both sides. Discussed upside: The bull case for Ainos, Inc. centers on significant commercial and technological advancements, including a landmark $9 million AI Nose System agreement with ASE and the successful completion of the VELDONA technology transfer, which generated a substantial license payment. The company has also achieved a major milestone by surpassing 3 billion real-world chemical data points, enhancing its chemical intelligence capabilities, and recent strong buying pressure has been noted. Discussed risks: The bear case for Ainos, Inc. highlights severe financial headwinds, characterized by a sharp year-over-year quarterly revenue decline of -96.7% and minimal trailing twelve months revenue. Profitability metrics are deeply negative, with a substantial EPS loss and a highly negative Return on Equity. Technical indicators also suggest a bearish short-term outlook with a downtrend indicated by long-term moving averages. These are descriptive observations, not a recommendation.
What is the latest sentiment on Ainos, Inc.?
News reports highlighted a significant new agreement for AI Nose Systems and a technology transfer, alongside advancements in data collection. Social media discussion focused on the company's operational progress and substantial order wins.
How does Market Scanner analyse Ainos, Inc.?
Every analysis of Ainos, Inc. runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.
Read the methodology- Bundles used
- gemini-low-v2
Run a fresh AIMD.US analysis
Configure the ticker, model bundle and debate depth here — you only sign in at the end, and everything you picked comes with you.